Key facts
- This page summarizes Douglas E. Coltharp's Form 4 filing for Encompass Health Corp (EHC).
- 7 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 30 Apr 2025, 13:24.
Douglas E. Coltharp - 29 Apr 2025 Form 4 Insider Report for Encompass Health Corp (EHC)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- EHC
- Reported as of
- 29 Apr 2025
- Net transaction value
- -$3,644,548
- SEC form
- 4
- Accepted by SEC
- 30 Apr 2025, 13:24:38 UTC
- Prior SEC filing
- 02 Apr 2025
- Next SEC filing
- 03 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patrick Darby, attorney-in-fact for Mr. Coltharp
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Douglas E. Coltharp filed Form 4 for Encompass Health Corp (EHC) on 30 Apr 2025.
Change
- Previous filing in this sequence was filed on 02 Apr 2025.
- Current net transaction value: -$3,644,548.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EHC
transaction
Encompass Health Common Stock
Options Exercise
- Transaction value
- $467,140
- Shares
- +16,075
- Change %
- +27%
- Price
- $29.06
- Shares after
- 76,410
- Date
- 29 Apr 2025
- Ownership
- Direct
EHC
transaction
Encompass Health Common Stock
Options Exercise
- Transaction value
- $905,850
- Shares
- +27,500
- Change %
- +36%
- Price
- $32.94
- Shares after
- 103,910
- Date
- 29 Apr 2025
- Ownership
- Direct
EHC
transaction
Encompass Health Common Stock
Sale
- Transaction value
- -$3,011,712
- Shares
- -26,239
- Change %
- -25%
- Price
- $114.78
- Shares after
- 77,671
- Date
- 29 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
EHC
transaction
Encompass Health Common Stock
Sale
- Transaction value
- -$1,548,065
- Shares
- -13,402
- Change %
- -17%
- Price
- $115.51
- Shares after
- 64,269
- Date
- 29 Apr 2025
- Ownership
- Direct
- Footnotes
- F2
EHC
transaction
Encompass Health Common Stock
Sale
- Transaction value
- -$457,760
- Shares
- -3,934
- Change %
- -6.1%
- Price
- $116.36
- Shares after
- 60,335
- Date
- 29 Apr 2025
- Ownership
- Direct
- Footnotes
- F3
EHC
holding
Encompass Health Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 125,631
- Date
- 29 Apr 2025
- Ownership
- By irrevocable trust for the benefit of children
EHC
holding
Encompass Health Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 65,229
- Date
- 29 Apr 2025
- Ownership
- By spouse
- Footnotes
- F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EHC
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -16,075
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 29 Apr 2025
- Ownership
- Direct
- Underlying class
- Encompass Health Common Stock
- Underlying amount
- 16,075
- Exercise price
- $29.06
- Footnotes
- F5
EHC
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -27,500
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 27,694
- Date
- 29 Apr 2025
- Ownership
- Direct
- Underlying class
- Encompass Health Common Stock
- Underlying amount
- 27,500
- Exercise price
- $32.94
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.22 to $115.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Footnote F2
This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.22 to $116.21, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Footnote F3
This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.22 to $116.57, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
Footnote F4
The reporting person disclaims beneficial ownership of the securities held by his spouse, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Footnote F5
The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.